| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.01 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.12 | 0.02 |